TIKIZ, C. Et Al. 2005. Selective COX-2 inhibition with different doses of rofecoxib does not impair endothelial function in patients with coronary artery disease. Acta Medica Okayama , vol.59, no.1 , 11-17.

TIKIZ, C., Ütük, O., BAYTURAN, Ö., Bayindir, P., Ekmekçi, C., & TIKIZ, H., (2005). Selective COX-2 inhibition with different doses of rofecoxib does not impair endothelial function in patients with coronary artery disease. Acta Medica Okayama , vol.59, no.1, 11-17.

TIKIZ, CANAN Et Al. "Selective COX-2 inhibition with different doses of rofecoxib does not impair endothelial function in patients with coronary artery disease," Acta Medica Okayama , vol.59, no.1, 11-17, 2005

TIKIZ, CANAN Et Al. "Selective COX-2 inhibition with different doses of rofecoxib does not impair endothelial function in patients with coronary artery disease." Acta Medica Okayama , vol.59, no.1, pp.11-17, 2005

TIKIZ, C. Et Al. (2005) . "Selective COX-2 inhibition with different doses of rofecoxib does not impair endothelial function in patients with coronary artery disease." Acta Medica Okayama , vol.59, no.1, pp.11-17.

@article{article, author={CANAN TIKIZ Et Al. }, title={Selective COX-2 inhibition with different doses of rofecoxib does not impair endothelial function in patients with coronary artery disease}, journal={Acta Medica Okayama}, year=2005, pages={11-17} }